Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
for Bradyarrhythmia Management
Model 3830 is a MR Conditional-licensed pacing lead for conduction system pacing, to help treat bradycardia patients who have a pacemaker.
The 3830 lead is licenced for providing conduction system pacing in Canada, including both His-bundle pacing (HBP) and left bundle branch area pacing (LBBAP).
Conduction system pacing (CSP) is licenced to provide physicians an alternative to right ventricular pacing in a single or dual chamber pacing system in bradycardia patients.
Health Canada licensed MR Conditional lead for left bundle branch area pacing, when paired with Medtronic MRI SureScan systems.
3830 use in the left bundle branch area is supported by real-world evidence encompassing 20k+ patients.1
3830 has a novel lumenless design and fixed helix, allowing for increased helix stability at implant relative to extendable/retractable helix leads.1,2
The fatigue performance of the 3830 lead in a left bundle branch area position compares to performance in the RV (98% reliability, 95% CI) based on simulated 10-year testing.3
MR Conditional lead for His bundle pacing and left bundle branch area pacing, when paired with Medtronic MRI SureScan systems.
Preshaped deflectable catheter with out-of-plane “His” curve.
Preshaped catheter with out-of-plane “His” curve.
SelectSecure 3830 Left Bundle Branch Area Pacing Safety and Efficacy Utilizing RWE. Medtronic data on file.
Riley WF, Zachary LW. Introduction to Mechanics of Materials. Hoboken, NJ: Wiley; 1989.
Zou J, Chen K, Liu X, et al. Clinical use conditions of lead deployment and simulated lead fracture rate in left bundle branch area pacing. J Cardiovasc Electrophysiol. Published online February 4, 2023.
For a listing of indications, contraindications, precautions, warnings, potential adverse events and MRI information please refer to the device labeling.